From January 1, 2024 to February 2, 2024, the company has repurchased 4,017,200 shares, representing 1.73% for CNY 38.41 million. With this, the company has completed the repurchase of 4,017,200 shares, representing 1.73% for CNY 38.41 million under the buyback announced on December 23, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.44 CNY | +0.53% | +2.33% | -8.19% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.19% | 363M | |
+3.78% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.